Dr Edward Stevens has over 20 years’ experience in ion channel drug discovery. Before joining Metrion, Eddy held the position of Chief Scientific Officer at Ario Pharma, co-ordinating Ario’s TRPA1 lead discovery project in collaboration with a global pharmaceutical company.

Prior to this, Eddy spent 8 years at Pfizer, initially at Sandwich where he held the position of Head of Ion Channel Electrophysiology.

Eddy then moved to Pfizer Neusentis in Cambridge where he took up the same role. This included leading pharmacology support for all Neusentis ion channel programmes and included the management of a potassium channel programme which successfully progressed to lead development stage.

Prior to his role at Pfizer, Eddy was previously Chief Operating Officer of NeuroSolutions and Section Head at BioFocus (Charles River). He completed post-docs at the University of Cambridge and Parke-Davis UK.